Certain Common Stock of Bellevue Life Sciences Acquisition Corp. are subject to a Lock-Up Agreement Ending on 9-AUG-2023. These Common Stock will be under lockup for 181 days starting from 9-FEB-2023 to 9-AUG-2023.

Details:
The founder shares are subjected to lock-up for a period of 180 days immediately following the effective date of the registration statement related to the Proposed Public Offering.